Description: This session describes the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. We will walk through the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. We will also walk through some sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: This 1981 session focused on cost containment programs for health care in Canada and the US. Topics included: 1. Possible changes - improved plan design 2. Ways to stimulate change - market forces vs. regulation 3. Untapped cost control-health education for employees - health lifestyles & disease prevention 4. Information sources From Record of Society of Actuaries, Vol. 7, No. 2.

Description: This session discusses demographics of the uninsured & underinsured, needed core benefits, funding uncompensated care, state pools for high risk and near poor, the Massachusetts system, and the Kennedy-Waxman federal bills. From Record of the Society of Actuaries 1988 Vol. 14, No. 4B.

Description: This session discussion is about the effect of changes in medical practices and technology, effect of cost shifting, measurement and analysis and employers' perspective. From Record of the Society of Actuaries Vol. 15, No. 3A.

Description: This session discussion is about state-mandated health benefits. Who should decide and who should pay? The basis of making decisions, effect on insurance rates, impact on self-insurance, legislative process and timing of savings. From Record of Society of Actuaries Vol. 16, No. 1.

Description: This session discussion is about AIDS: Experience, trends and projections, medical and disability points of view, pricing, underwriting and epidemiologic implications and results of survey on current practices. From Record of Society of Actuaries Vol. 18, No. 1B.

Description: This is a discussion on group life and health products under conditions of inflation. It specifically highlights the development of alternative delivery systems such as Health Maintenance Organizations, the potential for further computerization of claim and record keeping, viability of new areas of coverage such as dental & vision and legal benefits, self-funding and administrative services only mechanisms, and the effect of inflation. From Record of the Society of Actuaries 1982, Volume 8, No. 1.

Description: Beginning with the 2019 Benefit Year, CMS (the Centers for Medicare and Medicaid Services) has provided guidance that allows Medicare Advantage Plan Sponsors much greater flexibility in tailoring benefits to promote clinical, care management, and financial goals. The guidance allows for a broader menu of supplemental benefits and also enables plans to target benefit enhancements to beneficiaries afflicted with specific disease states. This session explores the ramifications of the policy changes on Plan Sponsors and beneficiaries, and discusses the different ways that Plan Sponsors are taking advantage of the additional flexibility.

Description: Impact of Technology on Health Care Delivery Systems - Chart 2